According to preliminary data, Recordati achieved a net profit of 118.5 million in 2012, an increase of 1.8% on an annual basis. Consolidated revenues amounted to 828.3 million (+8.7%).
In detail, pharmaceutical sales amounted to 797.4 million (+8.7%) and those of pharmaceutical chemicals to 30.9 million (+8.9%). Operating profit increased by 2.1% to €167m.
At the end of December the net financial position showed a debt of 153.5 million compared to 55.7 million twelve months earlier.
«In the past year», commented the chairman and Giovanni Recordati [in the picture], «important transactions were concluded and significant results were obtained for the growth and internationalization of the group.
For 2013 we expect to achieve revenues of over 920 million, an operating profit of over 185 million and a net profit of over 128 million. Our three-year plan forecasts for 2015 to obtain revenues between 1.025 and 1.075 million, an operating profit between 210 and 220 million and a net profit between 140 and 150 million».
February 13, 2013
